Intact PTH is a significant determinant of serum sclerostin levels in healthy premenopausal and postmenopausal women [10, 35], patients with primary hyperparathyroidism [14], HD patients [8], and PD patients [34], but not in patients with non-dialyzed CKD [18]. This evidence concerns the gene SOST and primary hyperparathyroidism.